ArticleGene therapy2010

Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor.

T J Harvey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.